Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global Endovascular Aneurysm Repair Stent Grafts market was valued at USD 1.34 billion in 2024 and is projected to reach USD 1.98 billion by 2031, exhibiting a CAGR of 5.8% during the forecast period.
Endovascular aneurysm repair (EVAR) stent grafts are minimally invasive medical devices used to treat aortic aneurysms by excluding the aneurysm sac from blood flow and preventing rupture. These devices are deployed via catheter and consist of fabric grafts supported by metal stents, offering a less invasive alternative to traditional open surgery. The market growth is driven by increasing prevalence of aortic aneurysms, technological advancements in stent graft design, and growing adoption of minimally invasive procedures.
The market is experiencing steady growth due to several factors, including the rising geriatric population (increasing risk of aortic aneurysms), advancements in stent graft technology improving long-term outcomes, and expansion of healthcare infrastructure in emerging markets. Additionally, the growing adoption of endovascular procedures over open surgery due to shorter hospital stays and faster recovery times is contributing to market expansion. The market faces challenges such as high device costs, complex regulatory requirements, and limited availability in developing regions. However, ongoing clinical trials and new product launches by key players continue to drive innovation.
Aging Population Demographics
The growing geriatric population globally is a primary driver for the endovascular aneurysm repair stent grafts market. As age increases, so does the prevalence of aortic aneurysms, creating sustained demand for these life-saving devices.
Technological Advancements in Minimally Invasive Procedures
Continuous innovation in endovascular technologies has significantly improved patient outcomes. The development of lower-profile devices, enhanced stent graft materials, and improved delivery systems have made these procedures accessible to a wider patient population.
The global endovascular aneurysm repair market is projected to reach $3.8 billion by 2028, growing at a CAGR of 7.2%
Increasing physician training programs and growing hospital investments in hybrid operating rooms are further accelerating market adoption of these advanced technologies.
MARKET CHALLENGES
High Procedure Costs and Reimbursement Limitations
Endovascular aneurysm repair procedures involve significant costs including the stent graft device itself, imaging equipment, and specialized surgical teams. Many healthcare systems face budget constraints that limit widespread adoption, particularly in developing regions where the need is equally significant.
Other Challenges
Device Complexity and Training Requirements
The sophisticated nature of endovascular stent graft systems requires extensive physician training. The learning curve for complex procedures can be steep, and inadequate training remains a barrier to widespread adoption in some regions.
Stringent Regulatory Requirements
Endovascular stent grafts are classified as Class III medical devices, requiring extensive clinical data and regulatory approvals. The lengthy and expensive approval process can delay market entry for new technologies and limit competition in some markets.
Emerging Markets and Untapped Potential
Developing economies with growing healthcare infrastructure present significant growth opportunities. Countries like India, Brazil, and several Southeast Asian nations are investing in advanced medical technologies, creating new markets for endovascular stent graft manufacturers.
Technological Convergence and Hybrid Solutions
The integration of advanced imaging, robotics, and artificial intelligence with endovascular procedures creates new opportunities. Hybrid operating rooms that combine angiography with surgical capabilities are becoming more common, enabling complex cases that were previously inoperable.
Personalized Medicine and Patient-Specific Devices
Advancements in 3D printing and computational modeling enable creation of patient-specific stent grafts for complex anatomies. This personalized approach addresses one of the major limitations of current devices and opens new market segments.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Fenestrated Stent Grafts are gaining prominence for complex aortic anatomies due to their ability to preserve vital branch vessels while providing effective aneurysm exclusion, reflecting a shift toward more personalized and anatomy-specific treatment approaches. |
| By Application |
|
The Abdominal Aortic Aneurysm segment remains the dominant application due to higher prevalence rates and established treatment protocols, though complex thoracoabdominal cases are showing the fastest growth as physicians gain expertise with advanced endovascular techniques and imaging guidance. |
| By End User | COMPETITIVE LANDSCAPE
Key Industry PlayersCompanies Strengthen Product Portfolios to Secure Market Share Cook Medical, a Cook Group company (USA), has established itself as a market leader through its innovative Zenith Flex endovascular graft with the proprietary Captivia Delivery System, offering precise deployment and enhanced conformability. The company maintains significant market share through extensive clinical data and long-term follow-up studies that demonstrate strong clinical outcomes. Medtronic plc (Ireland) maintains strong competitive positioning with its Valiant Navion thoracic stent graft system, which features advanced sealing technology and improved flexibility for complex anatomies. The company's global distribution network and established reimbursement pathways in key markets contribute significantly to its market position. Endologix Inc. (USA) continues to innovate with its AFX2 Endovascular AAA System, which offers a unique anatomical fixation design that reduces migration risk. The company's focus on physician training and procedural support has strengthened its position among vascular surgeons and interventional radiologists. W. L. Gore & Associates (USA) leverages its expertise in material science with the EXCLUDER iliac branch endoprosthesis, featuring low-permeability ePTFE and active sac management capabilities. The company's investment in next-generation delivery systems and customized solutions for complex cases continues to drive adoption in tertiary care centers. List of Key Endovascular Aneurysm Repair Stent Graft Companies Profiled
Minimally Invasive Procedure Adoption AcceleratesEndovascular aneurysm repair (EVAR) procedures using stent grafts continue to displace traditional open surgical approaches across global markets. The shift is driven by superior patient outcomes including reduced hospitalization stays (average 2.5 days versus 7.2 days for open surgery), lower perioperative mortality (1.8% versus 6.5%), and significantly reduced blood loss (approximately 450mL less). Healthcare cost analysis shows EVAR procedures provide 23-31% savings in total treatment costs despite higher device costs, making them increasingly attractive to healthcare systems. Other Trends Aortic Anatomy Customization Manufacturers are responding to diverse patient anatomies with next-generation stent graft designs featuring enhanced flexibility, precision deployment, and improved sealing technologies. The market shows strong adoption of physician-modified endografts and off-label use of devices for complex anatomies, growing at approximately 14% annually. Custom fenestrations and branched designs now address approximately 37% of juxtarenal and thoracoabdominal cases that were previously considered inoperable. Emerging Markets Drive Volume GrowthWhile North America and Europe maintain 68% market share, the Asia-Pacific region demonstrates the fastest growth at 19% CAGR, driven by increasing physician training programs, healthcare infrastructure development, and aging populations. Latin American markets show particular strength in private healthcare adoption of advanced endovascular techniques, with Brazil and Mexico showing 22% and 18% growth respectively in the last two years. International regulatory harmonization has accelerated device approvals, with 78% of new EVAR devices receiving CE Mark and FDA approval within 12 months of each other. This convergence supports global market expansion and enables faster technology transfer to emerging markets where aortic disease burden remains significantly underdiagnosed and undertreated. Regional Analysis: Endovascular Aneurysm Repair Stent Grafts Market
North America
North America dominates the endovascular aneurysm repair stent grafts market, driven by high healthcare expenditure, advanced healthcare infrastructure, and high adoption rates of minimally invasive surgical procedures. The region benefits from a favorable reimbursement landscape with Medicare and private insurers providing substantial coverage for these advanced procedures. The presence of leading medical device companies and their robust R&D investments in developing next-generation stent grafts further strengthens the region's dominance. The high prevalence of abdominal aortic aneurysms in the aging population, combined with increasing awareness and screening programs, creates sustained demand. Regulatory approvals from the FDA for innovative stent graft designs continue to facilitate market growth, with surgeons in this region often being early adopters of the latest technological advancements.
Rising Healthcare Investments
Europe's market growth is propelled by increased healthcare spending and government initiatives to improve vascular surgery capabilities. Countries like Germany, France, and the UK are investing in specialized endovascular surgery units within major hospitals, equipped with hybrid operating rooms that combine angiography and surgical facilities. This infrastructure supports complex procedures and training programs that increase surgeon adoption rates.
Aging Population Dynamics
Asia-Pacific shows the fastest growth rate due to rapidly aging populations in Japan, South Korea, and increasingly in China. The demographic shift toward older age groups creates sustained demand for endovascular repair procedures. Governments are increasing healthcare spending to address this demographic shift, with Japan's universal healthcare system providing strong coverage for these procedures, driving adoption rates.
Medical Tourism Growth
Countries like South Korea, India, and Thailand are developing as hubs for complex endovascular procedures, attracting patients from across the region. This is supported by investments in state-of-the-art medical facilities and the availability of latest-generation stent graft devices. Governments are supporting this trend through regulatory reforms that streamline approval processes for new medical devices.
Specialized Training Programs
Regions with developing healthcare systems are showing increased adoption through specialized training programs for vascular surgeons. International collaborations between medical schools and device manufacturers help transfer knowledge about latest techniques. This is particularly evident in countries like Brazil and Mexico, where medical associations are actively organizing workshops and cadaver labs to increase surgeon competency with newer generation devices. Europe Asia-Pacific Latin America Middle East & Africa Report ScopeThis market research report offers a holistic overview of the global and regional markets for endovascular aneurysm repair stent grafts for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research, covering market size, competitive landscape, segmentation, and key trends. Key Coverage Areas:
FREQUENTLY ASKED QUESTIONS:What is the current market size of Global Endovascular Aneurysm Repair Stent Grafts Market?-> Global endovascular aneurysm repair stent grafts market was valued at USD 1342 million in 2024 and is projected to reach USD 1985 million by 2031. Which key companies operate in Global Endovascular Aneurysm Repair Stent Grafts Market?-> Key players include Medtronic, Cook Medical, Terumo, MicroPort Scientific, and Lifetech Scientific, among others. What are the key growth drivers?-> Key growth drivers include increasing prevalence of aortic aneurysms, technological advancements in stent graft design, and growing adoption of minimally invasive procedures. Which region dominates the market?-> North America and Europe are the main markets, while Asia-Pacific shows the fastest growth potential. What are the emerging trends?-> Emerging trends include development of bio-based coatings, smart stent technologies, and expansion of personalized treatment solutions. Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Endovascular Aneurysm Repair Stent Grafts Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 Global Endovascular Aneurysm Repair Stent Grafts Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Endovascular Aneurysm Repair Stent Grafts Overall Market Size 2.1 Global Endovascular Aneurysm Repair Stent Grafts Market Size: 2024 VS 2031 2.2 Global Endovascular Aneurysm Repair Stent Grafts Market Size, Prospects & Forecasts: 2020-2031 2.3 Global Endovascular Aneurysm Repair Stent Grafts Sales: 2020-2031 3 Company Landscape 3.1 Top Endovascular Aneurysm Repair Stent Grafts Players in Global Market 3.2 Top Global Endovascular Aneurysm Repair Stent Grafts Companies Ranked by Revenue 3.3 Global Endovascular Aneurysm Repair Stent Grafts Revenue by Companies 3.4 Global Endovascular Aneurysm Repair Stent Grafts Sales by Companies 3.5 Global Endovascular Aneurysm Repair Stent Grafts Price by Manufacturer (2020-2025) 3.6 Top 3 and Top 5 Endovascular Aneurysm Repair Stent Grafts Companies in Global Market, by Revenue in 2024 3.7 Global Manufacturers Endovascular Aneurysm Repair Stent Grafts Product Type 3.8 Tier 1, Tier 2, and Tier 3 Endovascular Aneurysm Repair Stent Grafts Players in Global Market 3.8.1 List of Global Tier 1 Endovascular Aneurysm Repair Stent Grafts Companies 3.8.2 List of Global Tier 2 and Tier 3 Endovascular Aneurysm Repair Stent Grafts Companies 4 Sights by Product 4.1 Overview 4.1.1 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Market Size Markets, 2024 & 2031 4.1.2 Straight Pipe Stent 4.1.3 Branched Stent 4.1.4 Bifurcated Stent 4.2 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Revenue & Forecasts 4.2.1 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Revenue, 2020-2025 4.2.2 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Revenue, 2026-2032 4.2.3 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Revenue Market Share, 2020-2031 4.3 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Sales & Forecasts 4.3.1 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Sales, 2020-2025 4.3.2 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Sales, 2026-2032 4.3.3 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Sales Market Share, 2020-2031 4.4 Segment by Type - Global Endovascular Aneurysm Repair Stent Grafts Price (Manufacturers Selling Prices), 2020-2031 5 Sights by Application 5.1 Overview 5.1.1 Segment by Application - Global Endovascular Aneurysm Repair Stent Grafts Market Size, 2024 & 2031 5.1.2 Aortic Aneurysm Treatment 5.1.3 Aortic Dissection Treatment 5.1.4 Complex Aortic Lesions Treatment 5.1.5 Individualized Treatment 5.2 Segment by Application - Global Endovascular Aneurysm Repair Stent Grafts Revenue & Forecasts Our Clients
Testimonials“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.” “We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.” “I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.” “Their custom report on clinical trial trends was a helpful reference as we explored new indications." “As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.” “We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.” “Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.” “I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.” Starting
From
$
995 USD
What Sets Us ApartAt 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action. 
Data AccuracyVerified InsightsPrecision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources. 
Security & ConfidentialityEnterprise SecurityWe uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources. 
Trusted by ExpertsTrusted by 75+ Fortune 500s24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide. 
No Hidden CostsQuality Insights, Honest PricingWe offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need. 
Expertise in
|
